In3gredients, Inc. – Trademark Portfolio
Entity Type: 03
In3gredients, Inc. has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include PEPTINEX. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 1 (Chemicals) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in Chicago, IL.
30 North Michigan Avenue, Suite 1412
Chicago, IL 60602
Showing of trademarks Trademarks
Trademark Classifications
In3gredients, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does In3gredients, Inc. have?
In3gredients, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does In3gredients, Inc. file in?
In3gredients, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are In3gredients, Inc.'s most well-known trademarks?
In3gredients, Inc.'s registered trademark portfolio includes well-known marks such as PEPTINEX. These are among 1 currently registered trademark in the portfolio.
What is In3gredients, Inc.'s trademark registration success rate?
In3gredients, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.